SARS-COV-2 -ASSOCIATED PNEUMONIA

Clinical trials for SARS-COV-2 -ASSOCIATED PNEUMONIA explained in plain language.

Never miss a new study

Get alerted when new SARS-COV-2 -ASSOCIATED PNEUMONIA trials appear

Sign up with your email to follow new studies for SARS-COV-2 -ASSOCIATED PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

New pill aims to keep pneumonia patients out of hospital

Disease control Terminated

This study tested whether adding an experimental drug called silmitasertib to standard care could help adults with pneumonia caused by COVID-19 or the flu. The goal was to see if the combination treatment could prevent patients from getting worse and needing to go to the hospital…

Matched conditions: SARS-COV-2 -ASSOCIATED PNEUMONIA

Phase: PHASE2 • Sponsor: Senhwa Biosciences, Inc. • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

SARS-COV-2 -ASSOCIATED PNEUMONIA

Get alerted when new SARS-COV-2 -ASSOCIATED PNEUMONIA trials appear

New pill aims to keep pneumonia patients out of hospital